NovaBridge Biosciences Statistics

Total Valuation

FRA:0VY has a market cap or net worth of EUR 380.74 million. The enterprise value is 241.28 million.

Market Cap	380.74M
Enterprise Value	241.28M

Important Dates

The next estimated earnings date is Tuesday, March 17, 2026.

Earnings Date	Mar 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	59.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	2.27
P/TBV Ratio	2.27
P/FCF Ratio	10.27
P/OCF Ratio	10.26
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.09
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	6.51

Financial Position

The company has a current ratio of 22.82, with a Debt / Equity ratio of 0.02.

Current Ratio	22.82
Quick Ratio	22.65
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	0.08
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -18.46% and return on invested capital (ROIC) is -10.82%.

Return on Equity (ROE)	-18.46%
Return on Assets (ROA)	-10.36%
Return on Invested Capital (ROIC)	-10.82%
Return on Capital Employed (ROCE)	-19.14%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +268.36% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+268.36%
50-Day Moving Average	3.81
200-Day Moving Average	2.29
Relative Strength Index (RSI)	43.34
Average Volume (20 Days)	707

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.26

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-32.50M
Pretax Income	-34.05M
Net Income	-34.05M
EBITDA	-32.43M
EBIT	-32.50M
Earnings Per Share (EPS)	-0.42

Full Income Statement

Balance Sheet

The company has 141.02 million in cash and 2.96 million in debt, giving a net cash position of 138.06 million.

Cash & Cash Equivalents	141.02M
Total Debt	2.96M
Net Cash	138.06M
Net Cash Per Share	n/a
Equity (Book Value)	167.52M
Book Value Per Share	2.05
Working Capital	136.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 37.12 million and capital expenditures -39,169, giving a free cash flow of 37.08 million.

Operating Cash Flow	37.12M
Capital Expenditures	-39,169
Free Cash Flow	37.08M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:0VY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.61%
Shareholder Yield	0.61%
Earnings Yield	-8.94%
FCF Yield	9.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3